BERGANTINI, LAURA
 Distribuzione geografica
Continente #
EU - Europa 983
NA - Nord America 933
AS - Asia 134
AF - Africa 11
SA - Sud America 10
OC - Oceania 2
Totale 2.073
Nazione #
US - Stati Uniti d'America 913
IT - Italia 482
IE - Irlanda 180
SE - Svezia 79
DE - Germania 64
FR - Francia 48
GB - Regno Unito 43
VN - Vietnam 36
CN - Cina 24
NL - Olanda 20
UA - Ucraina 16
IN - India 14
BE - Belgio 13
CA - Canada 12
JP - Giappone 11
CZ - Repubblica Ceca 8
MX - Messico 8
ZA - Sudafrica 7
AE - Emirati Arabi Uniti 6
EC - Ecuador 6
KR - Corea 6
ES - Italia 5
FI - Finlandia 5
HK - Hong Kong 5
ID - Indonesia 5
IR - Iran 5
RO - Romania 4
TR - Turchia 4
PH - Filippine 3
RU - Federazione Russa 3
TH - Thailandia 3
TW - Taiwan 3
BR - Brasile 2
IQ - Iraq 2
PL - Polonia 2
RS - Serbia 2
SI - Slovenia 2
UG - Uganda 2
AM - Armenia 1
AU - Australia 1
CH - Svizzera 1
CL - Cile 1
CO - Colombia 1
DZ - Algeria 1
GR - Grecia 1
HR - Croazia 1
IL - Israele 1
LT - Lituania 1
LU - Lussemburgo 1
MA - Marocco 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PT - Portogallo 1
QA - Qatar 1
SA - Arabia Saudita 1
SG - Singapore 1
UZ - Uzbekistan 1
Totale 2.073
Città #
Siena 226
Dublin 170
Ashburn 136
Fairfield 74
Stockholm 74
Santa Cruz 68
Seattle 47
Buffalo 38
Dong Ket 36
Houston 33
Woodbridge 30
Chicago 29
Cambridge 28
Southend 28
Milan 25
Wilmington 21
Florence 16
Shanghai 15
Cedar Knolls 14
Brussels 13
Brooklyn 12
Fleming Island 11
New York 11
Rome 11
Amsterdam 9
San Diego 9
Ann Arbor 8
Boardman 8
Council Bluffs 7
London 7
Los Angeles 7
Brescia 6
Las Vegas 6
Melito Irpino 6
Muizenberg 6
Arezzo 5
Athis-mons 5
Atlanta 5
Lake Forest 5
Paris 5
Tokyo 5
Dallas 4
Guayaquil 4
Henderson 4
Jakarta 4
Norfolk 4
Ponte Buggianese 4
Scranton 4
Beijing 3
Cagliari 3
Calgary 3
Catania 3
Helsinki 3
Kingston 3
Madison 3
Minneapolis 3
Naples 3
Pisa 3
Pune 3
Sunnyvale 3
Ancona 2
Bengaluru 2
Bergamo 2
Berlin 2
Bologna 2
Brookline 2
Clearwater 2
Crugers 2
Durham 2
Falkenstein 2
Genoa 2
Helsingborg 2
Herndon 2
Hong Kong 2
Jacksonville 2
Kampala 2
Kashan 2
Kumar 2
Lappeenranta 2
Longwood 2
Messina 2
Milpitas 2
Minamikoiwa 2
Montreal 2
Munich 2
Napoli 2
Nuremberg 2
Ottawa 2
Padova 2
Paglieta 2
Pamukkale 2
Parma 2
Phoenix 2
Portland 2
Prato 2
Provo 2
Quito 2
Rochester 2
Rotterdam 2
Saint Petersburg 2
Totale 1.419
Nome #
Pirfenidone in idiopathic pulmonary fibrosis: real-life experience in the referral centre of Siena, file e0feeaa9-152a-44d2-e053-6605fe0a8db0 146
Chitotriosidase: a biomarker of activity and severity in patients with sarcoidosis, file e0feeaa8-497f-44d2-e053-6605fe0a8db0 140
Prognostic Biomarkers of Sarcoidosis: A Comparative Study of Serum Chitotriosidase, ACE, Lysozyme, and KL-6, file e0feeaa7-f6b4-44d2-e053-6605fe0a8db0 135
null, file e0feeaaa-249a-44d2-e053-6605fe0a8db0 113
null, file e0feeaa9-5001-44d2-e053-6605fe0a8db0 107
Pleuroparenchymal fibroelastosis in patients affected by systemic sclerosis: What should the rheumatologist do?, file e0feeaa8-1fd0-44d2-e053-6605fe0a8db0 105
ACE2 gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population, file e0feeaa8-ceda-44d2-e053-6605fe0a8db0 89
Serum concentrations of Krebs von den Lungen-6 in different COVID-19 phenotypes, file e0feeaa9-3dd9-44d2-e053-6605fe0a8db0 86
Immune modulatory effects of novel monoclonal antibodies target therapies in severe eosinophilic asthma patients, file e0feeaa9-2887-44d2-e053-6605fe0a8db0 80
null, file e0feeaaa-1f34-44d2-e053-6605fe0a8db0 67
null, file e0feeaaa-52ef-44d2-e053-6605fe0a8db0 65
Follicular T Helper and Breg Cell Balance in Severe Allergic Asthma Before and After Omalizumab Therapy, file e0feeaaa-1130-44d2-e053-6605fe0a8db0 61
Adaptive immune system in pulmonary sarcoidosis - comparison of peripheral and alveolar biomarkers, file 1b8518ff-3a73-4507-8be4-6eb308bef028 56
A Comprehensive Review of Sarcoidosis Treatment for Pulmonologists, file e0feeaaa-35c6-44d2-e053-6605fe0a8db0 53
KL-6 in ANCA-Associated Vasculitis Patients with and without ILD: A Machine Learning Approach, file e0feeaab-34f2-44d2-e053-6605fe0a8db0 51
Prevalence of myositis specific and associated antibodies in a cohort of patients affected by idiopathic NSIP and no hint of inflammatory myopathies, file 65e2b7bb-fc24-4727-8ef0-f79ae28df84e 40
Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity, file e0feeaab-0099-44d2-e053-6605fe0a8db0 40
PD1, CTLA4 and TIGIT Expression on T and NK Cells in Granulomatous Diseases: Sarcoidosis and ANCA-Associated Vasculitis, file 1ee9d497-3650-41a3-b8b0-9d5031807bdb 38
The polymorphism L412F in TLR3 inhibits autophagy and is a marker of severe COVID-19 in males., file e8887f01-8ecd-408c-a6e4-5b1d8e6d5c42 38
Carriers of ADAMTS13 Rare Variants Are at High Risk of Life-Threatening COVID-19, file 96f4df86-86ac-462c-8a12-3ca958289b45 31
Immune-Checkpoint Expression on CD4, CD8 and NK Cells in Blood, Bronchoalveolar Lavage and Lymph Nodes of Sarcoidosis, file 1fd5c682-0c91-4969-b9d9-8023c29c016b 30
Alveolar concentration of nitric oxide as a prognostic biomarker in idiopathic pulmonary fibrosis, file e0feeaab-e140-44d2-e053-6605fe0a8db0 29
BAL Proteomic Signature of Lung Adenocarcinoma in IPF Patients and Its Transposition in Serum Samples for Less Invasive Diagnostic Procedures, file a9aa19de-f7e7-47f4-bd0e-0351d1b2750e 27
Multi-Omics Integrative Approach of Extracellular Vesicles: A Future Challenging Milestone, file ba6e2e89-23fa-45c2-90d2-bafd0ced1dc6 27
null, file e0feeaab-b657-44d2-e053-6605fe0a8db0 24
Evaluation of multiple-flows exhaled nitric oxide in idiopathic and non-idiopathic interstitial lung disease, file e0feeaab-da93-44d2-e053-6605fe0a8db0 24
Rare variants in Toll-like receptor 7 results in functional impairment and downregulation of cytokine-mediated signaling in COVID-19 patients, file e0feeaab-0e66-44d2-e053-6605fe0a8db0 23
Serial KL-6 measurements in COVID-19 patients, file e0feeaa9-6411-44d2-e053-6605fe0a8db0 21
null, file e0feeaaa-063d-44d2-e053-6605fe0a8db0 21
C9orf72 intermediate repeats confer genetic risk for severe covid-19 pneumonia independently of age, file 530676af-72b7-4a15-b48a-51204a80e40d 16
SARS-CoV-2 susceptibility and COVID-19 disease severity are associated with genetic variants affecting gene expression in a variety of tissues, file b27bf0e9-010f-47e6-a116-48649af66e36 16
Clinical and molecular characterization of COVID-19 hospitalized patients, file 125e504f-f9c2-4d04-8ea6-eb60ed7246fe 14
Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males, file 434b66aa-b383-4316-9027-8d28bd50a93f 14
Whole-genome sequencing reveals host factors underlying critical COVID-19, file b47ac884-9c8d-4cf9-84ab-2c6dfbaa52e5 13
Mapping the human genetic architecture of COVID-19, file e0feeaab-73d3-44d2-e053-6605fe0a8db0 13
Collagen Type IV Alpha 5 Chain in Bronchiolitis Obliterans Syndrome After Lung Transplant: The First Evidence, file 768cdf1a-a36a-43d1-b312-6d89719a3dcb 12
Gain- and Loss-of-Function CFTR Alleles Are Associated with COVID-19 Clinical Outcomes, file ebc57d5c-8d48-406c-b361-06dd583c7b6b 12
null, file 385893c5-b7c4-4d3e-a732-6db17b23ee3f 11
An explainable model of host genetic interactions linked to COVID-19 severity, file a40b8f9e-8132-42fb-ba8e-085aaa454eda 11
NK and NKT-like cells in granulomatous and fibrotic lung diseases, file e0feeaa8-419c-44d2-e053-6605fe0a8db0 11
Oxygen Therapy during Exercise in Patients with Interstitial Lung Diseases, file 595c0671-7c01-456b-92fe-7de9da027917 10
Cytomegalovirus Infection Is Associated with Development of Chronic Lung Allograft Dysfunction, file b7365529-c7fa-4757-b37a-a856cfddac4a 10
The effect of anti-IL5 monoclonal antibodies on regulatory and effector T cells in severe eosinophilic asthma, file 4e7221c9-6c05-49d5-a23f-f804cd5a74de 9
Markers of Bronchiolitis Obliterans Syndrome after Lung Transplant: Between Old Knowledge and Future Perspective, file e73530c8-7ca8-43dd-a310-259da1def566 9
Alveolar concentration of nitric oxide as a prognostic biomarker in idiopathic pulmonary fibrosis, file e0feeaa8-11e4-44d2-e053-6605fe0a8db0 8
null, file e0feeaa9-7c6e-44d2-e053-6605fe0a8db0 8
SARS-CoV-2 susceptibility and COVID-19 disease severity are associated with genetic variants affecting gene expression in a variety of tissues, file 4b6371f4-5458-443b-941a-cf972c6ace63 7
Benralizumab affects NK cell maturation and proliferation in severe asthmatic patients, file 5e7b7f53-fe9c-40cc-a216-e4b1542a360f 7
Characterization of NKG2-A/-C, Kir and CD57 on NK Cells Stimulated with pp65 and IE-1 Antigens in Patients Awaiting Lung Transplant, file c88bb55d-8bb0-4f5f-b0af-0d93aa85e5b5 6
Serial KL-6 analysis in patients with idiopathic pulmonary fibrosis treated with nintedanib, file e0feeaa7-e3d8-44d2-e053-6605fe0a8db0 6
null, file e0feeaa8-2038-44d2-e053-6605fe0a8db0 6
BAL biomarkers’ panel for differential diagnosis of interstitial lung diseases, file e0feeaa8-6197-44d2-e053-6605fe0a8db0 6
Serial KL-6 analysis in patients with idiopathic pulmonary fibrosis treated with nintedanib, file e0feeaa8-12ef-44d2-e053-6605fe0a8db0 5
Serum amyloid A: A potential biomarker of lung disorders, file e0feeaa8-9bf4-44d2-e053-6605fe0a8db0 5
Cytological analysis of bronchoalveolar lavage fluid in asbestos-exposed workers: BALF features in asbestos exposed workers, file e0feeaa9-2d73-44d2-e053-6605fe0a8db0 5
Serum amyloid A in patients with idiopathic pulmonary fibrosis, file e0feeaa8-11e7-44d2-e053-6605fe0a8db0 4
Rituximab Therapy in Interstitial Lung Disease associated with Rheumatoid Arthritis, file e0feeaa8-16fa-44d2-e053-6605fe0a8db0 4
Regulatory T Cells in Severe Persistent Asthma in the Era of Monoclonal Antibodies Target Therapies, file e0feeaa8-6217-44d2-e053-6605fe0a8db0 4
Bronchoalveolar lavage and serum KL-6 concentrations in chronic hypersensitivity pneumonitis: correlations with radiological and immunological features, file e0feeaa8-adec-44d2-e053-6605fe0a8db0 4
Serial investigation of Angiotensin-Converting Enzyme in sarcoidosis patients treated with Angiotensin-Converting Enzyme Inhibitor, file e0feeaa8-b7fe-44d2-e053-6605fe0a8db0 4
Proteomic characterization of idiopathic pulmonary fibrosis patients: stable versus acute exacerbation, file e0feeaa8-c971-44d2-e053-6605fe0a8db0 4
Serum KL-6 concentrations as a novel biomarker of severe COVID-19, file e0feeaa9-0e1f-44d2-e053-6605fe0a8db0 4
Prognostic bioindicators in severe COVID-19 patients, file e0feeaa9-449f-44d2-e053-6605fe0a8db0 4
Mepolizumab and Benralizumab in Severe Eosinophilic Asthma: Preliminary Results of a Proteomic Study, file e0feeaa9-5835-44d2-e053-6605fe0a8db0 4
Immunologic responses to antifibrotic treatment in IPF patients, file e0feeaaa-3a6f-44d2-e053-6605fe0a8db0 3
Differential redox proteomic profiles of serum from severe asthma patients after one month of Benralizumab and Mepolizumab treatment, file e0feeaaa-59c5-44d2-e053-6605fe0a8db0 3
Chitotriosidase: a biomarker of activity and severity in patients with sarcoidosis, file f08b5876-aaad-4894-b9a5-5d0d1dcf3d12 3
Employing a systematic approach to biobanking and analyzing clinical and genetic data for advancing COVID-19 research, file 2280e542-6881-4bb1-813e-9235d2285d2d 2
Bronchoalveolar-Lavage-Derived Fibroblast Cell Line (B-LSDM7) as a New Protocol for Investigating the Mechanisms of Idiopathic Pulmonary Fibrosis, file 91ec9de9-8671-4cb1-a792-84a2631f79fc 2
Protective Role of a TMPRSS2 Variant on Severe COVID-19 Outcome in Young Males and Elderly Women, file c44a78e1-66be-49a4-a3e1-68030161493b 2
The pathogenetic mechanisms of cough in idiopathic pulmonary fibrosis, file e0feeaa7-ae1d-44d2-e053-6605fe0a8db0 2
Serum amyloid A in patients with idiopathic pulmonary fibrosis, file e0feeaa8-2bc9-44d2-e053-6605fe0a8db0 2
Effects of rituximab therapy on B cell differentiation and depletion, file e0feeaa8-6dd4-44d2-e053-6605fe0a8db0 2
Idiopathic Pulmonary Fibrosis Serum proteomic analysis before and after nintedanib therapy, file e0feeaa9-0e1c-44d2-e053-6605fe0a8db0 2
A multicenter approach to evaluate omalizumab effectiveness in Samter’s triad, file e0feeaa9-4a30-44d2-e053-6605fe0a8db0 2
Ceruloplasmin and oxidative stress in severe eosinophilic asthma patients treated with Mepolizumab and Benralizumab, file e0feeaa9-4d7d-44d2-e053-6605fe0a8db0 2
Common molecular pathways targeted by nintedanib in cancer and IPF: a bioinformatic study, file e0feeaa9-62f6-44d2-e053-6605fe0a8db0 2
Interstitial lung disease associated with psoriatic arthritis: a new disease entity?, file e0feeaa9-75f8-44d2-e053-6605fe0a8db0 2
Clinical phenotyping in sarcoidosis management, file e0feeaaa-2fe7-44d2-e053-6605fe0a8db0 2
Genetic mechanisms of critical illness in COVID-19, file e0feeaaa-50e1-44d2-e053-6605fe0a8db0 2
High-dose steroids for the treatment of severe COVID-19: a new therapeutic tool?, file e0feeaaa-6dac-44d2-e053-6605fe0a8db0 2
Cytokine profiles in the detection of severe lung involvement in hospitalized patients with COVID-19: The IL-8/IL-32 axis, file e0feeaab-3a8a-44d2-e053-6605fe0a8db0 2
AB0611 Neutrophil extracellular traps and interstitial lung disease in ANCA-associated vasculitis: a scoping review, file 88b8a5a6-9db7-4ec4-9d2e-7f8d308b4977 1
Antithrombin III as predictive indicator of survival in IPF patients treated with Nintedanib: a preliminary study, file e0feeaa8-b15c-44d2-e053-6605fe0a8db0 1
Galactin-1, 3 and 9: Potential biomarkers in idiopathic pulmonary fibrosis and other interstitial lung diseases, file e0feeaa9-388a-44d2-e053-6605fe0a8db0 1
Adiponectin and leptin levels in idiopathic pulmonary fibrosis: A new method for BAL and serum assessment, file e0feeaa9-388e-44d2-e053-6605fe0a8db0 1
Peripheral biomarkers' panel for severe COVID-19 patients, file e0feeaa9-3a43-44d2-e053-6605fe0a8db0 1
Metabolic Dysregulation in Idiopathic Pulmonary Fibrosis, file e0feeaa9-44e9-44d2-e053-6605fe0a8db0 1
Utility of serological biomarker' panels for diagnostic accuracy of interstitial lung diseases, file e0feeaa9-4955-44d2-e053-6605fe0a8db0 1
Serum Amyloid A in lung transplantation, file e0feeaa9-4959-44d2-e053-6605fe0a8db0 1
The role of the combination of echo-HRCT score as a tool to evaluate the presence of pulmonary hypertension in idiopathic pulmonary fibrosis, file e0feeaa9-4d7b-44d2-e053-6605fe0a8db0 1
Extended Exhaled Nitric Oxide Analysis in Interstitial Lung Diseases: A Systematic Review, file e0feeaa9-5913-44d2-e053-6605fe0a8db0 1
Integrated approach to bronchoalveolar lavage cytology to distinguish interstitial lung diseases, file e0feeaaa-04b1-44d2-e053-6605fe0a8db0 1
Prognostic role of NK cell percentages in bronchoalveolar lavage from patients with different fibrotic interstitial lung diseases, file e0feeaaa-36b5-44d2-e053-6605fe0a8db0 1
Regulatory and Effector Cell Disequilibrium in Patients with Acute Cellular Rejection and Chronic Lung Allograft Dysfunction after Lung Transplantation: Comparison of Peripheral and Alveolar Distribution, file e0feeaaa-5422-44d2-e053-6605fe0a8db0 1
Evaluation of multiple-flows exhaled nitric oxide in idiopathic and non-idiopathic interstitial lung disease, file e0feeaaa-6529-44d2-e053-6605fe0a8db0 1
The Role of Galectins in Chronic Lung Allograft Dysfunction, file e0feeaaa-6da3-44d2-e053-6605fe0a8db0 1
Extracellular Vesicle Surface Signatures in IPF Patients: A Multiplex Bead-Based Flow Cytometry Approach, file e0feeaaa-6da5-44d2-e053-6605fe0a8db0 1
Prognostic role of KL-6 in SSc-ILD patients with pleuroparenchymal fibroelastosis, file e0feeaaa-6dae-44d2-e053-6605fe0a8db0 1
Strain echocardiography is a promising tool for the prognostic assessment of sarcoidosis, file e0feeaaa-da97-44d2-e053-6605fe0a8db0 1
Totale 2.110
Categoria #
all - tutte 7.563
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.563


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201927 0 0 0 0 0 0 0 0 2 1 6 18
2019/2020156 12 5 10 17 13 5 16 26 15 11 13 13
2020/2021323 16 9 8 24 10 28 25 27 18 48 50 60
2021/2022472 29 47 19 20 32 22 34 29 48 23 115 54
2022/2023549 20 25 88 64 35 80 37 37 57 30 47 29
2023/2024582 43 28 40 44 69 93 193 53 19 0 0 0
Totale 2.111